Medtronic announces outcomes from two studies in AFib patients
Medtronic (MDT) announced positive clinical outcomes from two studies in atrial fibrillation, AFib, patients treated with the Affera family of technologies, including the next-generation Sphere-360 single-shot pulsed field ablation catheter and the groundbreaking Sphere-9 combination mapping and dual-energy focal PFA catheter. Data were presented in High Impact Science Sessions at the Heart Rhythm Society 2025 Annual Meeting in San Diego; the Sphere-360 study was simultaneously published in the Heart Rhythm Journal. The company said; One-year clinical trial data for the next-generation, investigational, Sphere-360 single-shot PFA catheter show impressive safety, performance, and efficiency results for paroxysmal Afib; Dual-energy, focal Sphere-9 catheter demonstrates efficacy for linear ablation in persistent AFib; Medtronic continues legacy of leadership in innovation, showcasing arrhythmia management portfolio at Heart Rhythm Society annual meeting
Stay Ahead of the Market:
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 hours ago
- Yahoo
Hong Kong Hosts World's Largest ISSCR Stem Cell Gathering for the First Time
Some 2,400 stem cell and regenerative medicine pioneers convene to chart new frontiers, resulting from bidding efforts of Hong Kong Convention Ambassadors of the Hong Kong Tourism Board HONG KONG, HK / / June 11, 2025 / Reputed to be a leading research and development (R&D) hub for medical sciences, Hong Kong hosts the world's largest and most significant gathering of stem cell research and regenerative medicine, the International Society of Stem Cell Research (ISSCR) 2025 Annual Meeting. The event is brought to Hong Kong for the first time, thanks to the joint effort of three local universities - The University of Hong Kong, The Chinese University of Hong Kong and the Hong Kong University of Science and Technology, which are appointed organisations under the Hong Kong Convention Ambassador (HKCA) programme of the Hong Kong Tourism Board (HKTB). The four-day meeting held on June 11-14 gathers more than 2,400 local and international experts in stem cell research and regenerative medicine from 58 countries and regions, from Asia to North America, Europe, Australia, the Middle East, and Mainland China. Pioneers share the latest advances in the field, with topics spanning the field of regenerative medicine including topics such as advances in cell therapies, fundamental discoveries, understanding disease processes and more. Dr Peter Lam, HKTB Chairman, said, "The International Society for Stem Cell Research (ISSCR) is a globally leading organisation in medical sciences and research, and its annual meeting is one of the world's most significant international academic conventions in medical science. Hong Kong is the first city chosen to host this annual event in Asia after a 13-year hiatus, underscoring the city's status as the 'World's Meeting Place'. I am grateful for the active participation of the Hong Kong Convention Ambassadors from the three local universities, who leveraged their influence and network during the bidding for the host of the event to make the event come true. We are also delighted to see that more professionals from a wider range of expertise are joining HKTB's league of Convention Ambassadors, and we believe their participation can help identify and contribute to the staging of more significant international events in Hong Kong." Valentina Greco, ISSCR President, remarked, "Hosting ISSCR 2025 in Hong Kong marks a defining moment for global stem cell science. As a vibrant research hub at the crossroads of Asia and the world, Hong Kong offers an ideal setting to connect diverse scientific communities, spark new collaborations, and accelerate innovation. The ISSCR is deeply grateful to the city of Hong Kong and to our generous co-sponsors - the University of Hong Kong, The Chinese University of Hong Kong, and the Hong Kong University of Science and Technology - for their support and commitment to bringing The Global Stem Cell Event to this beautiful city. With the unwavering support of the Hong Kong Tourism Board, these three leading universities, and inspired leadership from our 2025 Annual Meeting Program Committee, this meeting exemplifies the power of partnership and shared vision. We are proud to return to Asia for the first time in more than a decade at a time when our collective progress in stem cell research and regenerative medicine and to advancing therapies that have life altering impact on patients depends on the exchange of bold ideas across borders." The extensive programme features plenary sessions, concurrent tracks, poster presentations, and networking opportunities. Contributing to the success of the event, the HKTB has provided comprehensive support, from arranging reconnaissance to venue sourcing, bid proposal, network support and more. Hong Kong Convention Ambassador Programme Aligns a Record Lineup of 180 Industry Leaders HKTB hosted the "Hong Kong Conference Ambassador Appreciation Night" last year to honor the contributions of the ambassadors in reinforcing Hong Kong as a "World Meeting Place" Hong Kong Convention Ambassadors from the Mainland recently participated in a business forum. HKCAs have been instrumental in winning the ISSCR 2025 Annual Meeting for Hong Kong. Launched in 2020 by the HKTB as a strategic initiative, the HKCA programme recruits high-level representatives of Hong Kong's eight universities, chambers of commerce, professional organisations, public bodies, industrial entities and professional societies to act as ambassadors for Hong Kong's convention sector. With their professional influence and networks, HKCAs have led efforts to bring in events ranging from medical sciences to innovation and technology (I&T), financial services, aviation, transportation and more. The close collaboration between HKCAs and the HKTB has proven effective in promoting Hong Kong as a premier hub for world-class conventions. As an alliance of distinguished local and Mainland leaders in business, medicine, professional services, I&T and other fields, the HKCA programme has been growing from strength to strength, with 72 new members in the latest record-sized cohort for the 2025-2026 term, taking the total to about 180, some 30% more than the previous cohort. Among the 76 international events for 2025 to 2027 lined up by the HKTB, with an estimated attendance of over 180,000 MICE visitor arrivals and 27 resulted from HKCAs' efforts. The events cover diverse fields ranging from I&T to aviation and medical sciences. Some are held in Hong Kong for the first time, including IEEE Electron Devices Technology and Manufacturing Conference held in March 2025, Routes World in September 2025 and World Cancer Congress 2026. The HKTB is committed to working closely with HKCAs to welcome more world-class events to Hong Kong, attracting high-yield overnight business visitors to the city and reinforcing the city's status as the world's meeting place. Large-scale conventions facilitated by Hong Kong Convention Ambassadors: Date Events (*first-ever in Hong Kong) Theme/Sector March 2025 IEEE Electron Devices Technology and Manufacturing Conference * Innovation & Technology May 2025 IEEE International Conference on Data Engineering Innovation & Technology Jun 2025 International Society for Stem Cell Research (ISSCR) Annual Meeting* Medical sciences Sep 2025 Routes World* Aviation Dec 2025 The International Society of Sport Psychology 16th World Congress Sports & Medical sciences 2026 Asia-Pacific Association for International Education 2026 Conference and Exhibition Education 2026 17th Asian Congress of Oral and Maxillofacial Surgery Medical sciences 2026 Asian Venture Philanthropy Network Conference Philanthropy 2026 International Federation of Landscape Architects World Congress Architecture 2026 Lions International Convention Social Services 2026 The Association of National Olympic Committees General Assembly Sports 2026 The Council Meeting of the Asian Patent Attorneys Association Intellectual property 2026 World Cancer Congress* Medical sciences 2027 International Association for Energy Economics Annual International Conference Economics 2027 Lions Clubs International Orient and Southeast Asian Lions Forum Social Services 2027 World Organization of Family Doctors Asia Pacific Regional Conference Medical sciences Ivy Chung Tel: 2807 6255 Email： Mr Leung Ho-yinTel: 2807 6358Email: SOURCE: Hong Kong Tourism Board View the original press release on ACCESS Newswire Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
6 hours ago
- Yahoo
Hong Kong Hosts World's Largest ISSCR Stem Cell Gathering for the First Time
Some 2,400 stem cell and regenerative medicine pioneers convene to chart new frontiers, resulting from bidding efforts of Hong Kong Convention Ambassadors of the Hong Kong Tourism Board HONG KONG, HK / / June 11, 2025 / Reputed to be a leading research and development (R&D) hub for medical sciences, Hong Kong hosts the world's largest and most significant gathering of stem cell research and regenerative medicine, the International Society of Stem Cell Research (ISSCR) 2025 Annual Meeting. The event is brought to Hong Kong for the first time, thanks to the joint effort of three local universities - The University of Hong Kong, The Chinese University of Hong Kong and the Hong Kong University of Science and Technology, which are appointed organisations under the Hong Kong Convention Ambassador (HKCA) programme of the Hong Kong Tourism Board (HKTB). The four-day meeting held on June 11-14 gathers more than 2,400 local and international experts in stem cell research and regenerative medicine from 58 countries and regions, from Asia to North America, Europe, Australia, the Middle East, and Mainland China. Pioneers share the latest advances in the field, with topics spanning the field of regenerative medicine including topics such as advances in cell therapies, fundamental discoveries, understanding disease processes and more. Dr Peter Lam, HKTB Chairman, said, "The International Society for Stem Cell Research (ISSCR) is a globally leading organisation in medical sciences and research, and its annual meeting is one of the world's most significant international academic conventions in medical science. Hong Kong is the first city chosen to host this annual event in Asia after a 13-year hiatus, underscoring the city's status as the 'World's Meeting Place'. I am grateful for the active participation of the Hong Kong Convention Ambassadors from the three local universities, who leveraged their influence and network during the bidding for the host of the event to make the event come true. We are also delighted to see that more professionals from a wider range of expertise are joining HKTB's league of Convention Ambassadors, and we believe their participation can help identify and contribute to the staging of more significant international events in Hong Kong." Valentina Greco, ISSCR President, remarked, "Hosting ISSCR 2025 in Hong Kong marks a defining moment for global stem cell science. As a vibrant research hub at the crossroads of Asia and the world, Hong Kong offers an ideal setting to connect diverse scientific communities, spark new collaborations, and accelerate innovation. The ISSCR is deeply grateful to the city of Hong Kong and to our generous co-sponsors - the University of Hong Kong, The Chinese University of Hong Kong, and the Hong Kong University of Science and Technology - for their support and commitment to bringing The Global Stem Cell Event to this beautiful city. With the unwavering support of the Hong Kong Tourism Board, these three leading universities, and inspired leadership from our 2025 Annual Meeting Program Committee, this meeting exemplifies the power of partnership and shared vision. We are proud to return to Asia for the first time in more than a decade at a time when our collective progress in stem cell research and regenerative medicine and to advancing therapies that have life altering impact on patients depends on the exchange of bold ideas across borders." The extensive programme features plenary sessions, concurrent tracks, poster presentations, and networking opportunities. Contributing to the success of the event, the HKTB has provided comprehensive support, from arranging reconnaissance to venue sourcing, bid proposal, network support and more. Hong Kong Convention Ambassador Programme Aligns a Record Lineup of 180 Industry Leaders HKTB hosted the "Hong Kong Conference Ambassador Appreciation Night" last year to honor the contributions of the ambassadors in reinforcing Hong Kong as a "World Meeting Place" Hong Kong Convention Ambassadors from the Mainland recently participated in a business forum. HKCAs have been instrumental in winning the ISSCR 2025 Annual Meeting for Hong Kong. Launched in 2020 by the HKTB as a strategic initiative, the HKCA programme recruits high-level representatives of Hong Kong's eight universities, chambers of commerce, professional organisations, public bodies, industrial entities and professional societies to act as ambassadors for Hong Kong's convention sector. With their professional influence and networks, HKCAs have led efforts to bring in events ranging from medical sciences to innovation and technology (I&T), financial services, aviation, transportation and more. The close collaboration between HKCAs and the HKTB has proven effective in promoting Hong Kong as a premier hub for world-class conventions. As an alliance of distinguished local and Mainland leaders in business, medicine, professional services, I&T and other fields, the HKCA programme has been growing from strength to strength, with 72 new members in the latest record-sized cohort for the 2025-2026 term, taking the total to about 180, some 30% more than the previous cohort. Among the 76 international events for 2025 to 2027 lined up by the HKTB, with an estimated attendance of over 180,000 MICE visitor arrivals and 27 resulted from HKCAs' efforts. The events cover diverse fields ranging from I&T to aviation and medical sciences. Some are held in Hong Kong for the first time, including IEEE Electron Devices Technology and Manufacturing Conference held in March 2025, Routes World in September 2025 and World Cancer Congress 2026. The HKTB is committed to working closely with HKCAs to welcome more world-class events to Hong Kong, attracting high-yield overnight business visitors to the city and reinforcing the city's status as the world's meeting place. Large-scale conventions facilitated by Hong Kong Convention Ambassadors: Date Events (*first-ever in Hong Kong) Theme/Sector March 2025 IEEE Electron Devices Technology and Manufacturing Conference * Innovation & Technology May 2025 IEEE International Conference on Data Engineering Innovation & Technology Jun 2025 International Society for Stem Cell Research (ISSCR) Annual Meeting* Medical sciences Sep 2025 Routes World* Aviation Dec 2025 The International Society of Sport Psychology 16th World Congress Sports & Medical sciences 2026 Asia-Pacific Association for International Education 2026 Conference and Exhibition Education 2026 17th Asian Congress of Oral and Maxillofacial Surgery Medical sciences 2026 Asian Venture Philanthropy Network Conference Philanthropy 2026 International Federation of Landscape Architects World Congress Architecture 2026 Lions International Convention Social Services 2026 The Association of National Olympic Committees General Assembly Sports 2026 The Council Meeting of the Asian Patent Attorneys Association Intellectual property 2026 World Cancer Congress* Medical sciences 2027 International Association for Energy Economics Annual International Conference Economics 2027 Lions Clubs International Orient and Southeast Asian Lions Forum Social Services 2027 World Organization of Family Doctors Asia Pacific Regional Conference Medical sciences Ivy Chung Tel: 2807 6255 Email： Mr Leung Ho-yinTel: 2807 6358Email: SOURCE: Hong Kong Tourism Board View the original press release on ACCESS Newswire Sign in to access your portfolio
Yahoo
17 hours ago
- Yahoo
BrainScope Expands Board and Launches Advanced Deep Learning Platform to Enhance Brain Health Insights
BETHESDA, Md., June 11, 2025--(BUSINESS WIRE)--BrainScope®, a leader in AI-enabled EEG technology for brain health assessment, today announced the launch of its next-generation deep learning platform. BrainScope developed and has commercialized the first FDA-cleared AI/machine learning medical device in the field of neurology. Building on that foundation in machine learning, BrainScope's new capabilities enhance its ability to deliver fast, objective, and clinically actionable insights across brain health conditions including concussion, stroke, and early Alzheimer's detection. The integration of deep learning into BrainScope's proprietary platform marks a major leap forward in automated EEG analysis. BrainScope's new Large Neural Model platform brings many of the breakthroughs of Large Language Models (LLMs) to bear on EEG data, eliminating the need for specialized qEEG interpretation. This novel and proprietary approach enhances BrainScope's first-in-class machine learning foundation, with the potential to significantly expand its utility across clinical care, research, and biopharma by enabling the development of more refined biomarkers to support precision-driven clinical trial recruitment, early diagnosis, personalized treatment, and improved patient outcomes. To help guide the company as it expands its clinical program and commercial activities, BrainScope has announced key updates to its Board of Directors. Ralph Terkowitz, who has served on BrainScope's Board since 2023, has been elected Chairman. A former General Partner at ABS Capital Partners, Terkowitz brings decades of experience helping technology companies grow and scale. He also serves on the Board of The 10,000 Brains Project and is Co-Chairman of The Robert Packard Center for ALS Research at Johns Hopkins. In his expanded role, Terkowitz will guide BrainScope's continued growth and adoption of its AI-powered brain health platform. Also joining the Board are Mike Genau, a seasoned global MedTech executive and former President of Medtronic's Americas Region, and Brian Shea, who oversees healthcare investments and deal origination as Head of Origination at Aon Advantage Funds. Genau led a $7B business unit at Medtronic and brings deep expertise in scaling medical technologies and guiding commercial strategy. Shea offers a valuable perspective at the intersection of finance, healthcare, and technology. "We're thrilled to elevate Ralph to the Chairman role and honored to welcome Mike and Brian to our Board during this pivotal moment in BrainScope's evolution," said Laurie Silver, CEO of BrainScope. "Ralph has been an invaluable advisor as we've developed and launched our next-generation EEG-based Large Neural Model platform. Mike's leadership in MedTech and Brian's strategic investment insight will be beneficial as we scale commercially, drive clinical innovation in expanded markets, and bring in new investment partners. To reflect our expanded capabilities, we've also launched a new website showcasing our deep learning technology and broader brain health mission." "It's exciting to take on the role of Chairman at such a transformative time," said Ralph Terkowitz. "BrainScope is turning groundbreaking science into meaningful real-world impact, and has demonstrated success in using qEEG coupled with computational neuroscience as a diagnostic tool to aid in assessment of many neurological conditions including stroke, concussions, and early Alzheimer's. I look forward to helping the team expand this potentially groundbreaking opportunity." About BrainScope BrainScope is a leading neurotechnology company with over 15 years of experience advancing brain health through objective, AI-powered insights derived from brain electrical activity (EEG). Its proprietary platform analyzes EEG data from any source using advanced machine and deep learning to deliver rapid, radiation-free, accessible and cost-effective biomarkers - greatly expanding the clinical utility of traditional EEG. BrainScope's initial commercial product remains the only point-of-care technology that objectively assesses head-injured patients for both brain bleeds and concussions. The company is now advancing novel biomarkers for early Alzheimer's detection, ARIA assessment, rapid stroke evaluation, concussion subtyping, military blast exposure, and brain fog. For more information, please visit View source version on Contacts Media Contact: Kissy BlackLotos Nile615-310-1894info@ Fehler beim Abrufen der Daten Melden Sie sich an, um Ihr Portfolio aufzurufen. Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten
